ArticleCardiovascular & hematological disorders drug targets2026
Evaluation of Cardiovascular Effects of the Hydroalcoholic Fruit Extract of
Article in Cardiovascular & hematological disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDue to the lack of sufficient studies on the mechanisms of the cardiovascular effects of Berberis vulgaris (B. vulgaris), this study aimed to evaluate the cardiovascular effects of the hydroalcoholic extract of B. vulgaris fruit on nitric oxide (NO) and acute hypertension caused by NG-nitro-L-arginine methyl ester (L-NAME; a NOS inhibitor).
methodsIn total, 48 male rats were assigned to six groups (n = 8): the control group, which received saline intraperitoneally (i.p), the L-NAME group, which received L-NAME intravenously (10 mg/kg. i.v), the L-NAME + SNP group, which received sodium nitroprusside (SNP, 50 μg/kg, i.v), followed by L-NAME after 30 min, and three treatment groups, which received the B. vulgaris extract at doses of 100, 200, and 400 mg/kg, followed by L-NAME. The heart rate (HR), mean arterial pressure (MAP), and systolic blood pressure (SBP) were measured up to 30 min after L-NAME injection. Afterward, changes (Δ) in SBP, MAP, and HR were calculated and analyzed.
resultsAll doses of the extract attenuated ΔSBP, ΔMAP, and ΔHR; however, these changes in the groups receiving the extract at the doses of 200 and 400 mg/kg were significantly lower than in the group receiving saline (P < 0.05-P < 0.01, respectively). In the L-NAME group, ΔSBP, ΔMAP, and ΔHR were significantly increased (P < 0.01-P < 0.001). In the L-NAME + SNP group, all responses were significantly lower than in the L-NAME group (P < 0.01-P < 0.001). The extract at the doses of 200 and 400 mg/kg significantly reduced ΔHR, ΔMAP, and ΔSBP induced by L-NAME (P < 0.05-P < 0.001). Moreover, these changes at the doses of 100 and 200 were significantly higher than in the L-NAME + SNP group. DISCUSSION: In the present study, it was demonstrated that the B. vulgaris extract dose dependently decreased cardiovascular parameters in basal and L-NAME-induced hypertensive conditions. This response suggests that the cardiovascular effect of the hydroalcoholic extract of B. vulgaris is partly mediated by an increase in NO production. Given the vasodilatory effect of NO, it seems that NO reduces vascular resistance and causes a decrease in blood pressure.
conclusionNO has a beneficial effect on the cardiovascular system, and the hypotensive effect of B. vulgaris extract is partly mediated by increased NO production.
Indexed as
Identifiers
41220264What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.